Gregg Fromell

2.2k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Gregg Fromell is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Gregg Fromell has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Gregg Fromell's work include Acute Myocardial Infarction Research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregg Fromell is often cited by papers focused on Acute Myocardial Infarction Research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregg Fromell collaborates with scholars based in United States, Canada and Argentina. Gregg Fromell's co-authors include Frédérique Bigonzi, Anatoly Langer, Enrique Gurfinkel, Keith A.A. Fox, Christine Demers, Alexander G.G. Turpie, Robert M. Califf, Jerôme Premmereur, Beth Davison Weatherley and Shaun Goodman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Gregg Fromell

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 1.0k citations Marc J. Cohen, Christine Demers et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Gregg Fromell

Since Specialization

Citations

This map shows the geographic impact of Gregg Fromell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg Fromell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg Fromell more than expected).

Fields of papers citing papers by Gregg Fromell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg Fromell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg Fromell. The network helps show where Gregg Fromell may publish in the future.

Co-authorship network of co-authors of Gregg Fromell

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg Fromell. A scholar is included among the top collaborators of Gregg Fromell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg Fromell. Gregg Fromell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States 2021 ·Clinical Transplantation ·(unknown), Daniel Schlauch, (unknown), (unknown), Ashraf Reyad, Mick Correll, Gregg Fromell, (unknown), Adam W. Bingaman, (unknown), Sridhar R. Allam	36
2	Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19 2021 ·Journal of Clinical Investigation ·(unknown), Angela G. Junglen, (unknown), (unknown), Casey Martin, Pratik Doshi, Daniel Schlauch, Gregg Fromell, Lindsay E. Sears, Mick Correll, Howard A. Burris, Charles F. LeMaistre	24
3	Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System 2020 ·Gastroenterology ·Samrat Yeramaneni, Pratik Doshi, Kenneth Sands, Mandelin Cooper, (unknown), Gregg Fromell	18
4	The Critical Need for Academic Health Centers to Assess the Training, Support, and Career Development Requirements of Clinical Research Coordinators: Recommendations from the Clinical and Translational Science Award Research Coordinator Taskforce* 2012 ·Clinical and Translational Science ·Lisa A. Speicher, Gregg Fromell, (unknown), (unknown), (unknown), Erika Stevens, (unknown)	47
5	Support for Investigator-Initiated Clinical Research Involving Investigational Drugs or Devices: The Clinical and Translational Science Award Experience 2010 ·Academic Medicine ·(unknown), Bruce K. Burnett, Gregg Fromell, Karen Hartman, Eric Rubinstein, Kathryn G. Schuff, Lisa A. Speicher	18
6	Good Clinical Practice Standards: What They Are and Some Tools to Support Them 2008 ·Human Gene Therapy ·Gregg Fromell	3
7	Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction 2001 ·The American Journal of Cardiology ·Scott D. Berkowitz, Sandra S. Stinnett, Marc Cohen, Gregg Fromell, Frédérique Bigonzi	25
8	Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52. 2000 ·Journal of the American College of Cardiology ·Shaun G. Goodman, Marc Cohen, Frédérique Bigonzi, David Radley, Gregg Fromell, Enrique Gurfinkel, (unknown), Christine Demers, Alexander G.G. Turpie, Robert M. Califf, Keith A.A. Fox, Anatoly Langer	105
9	Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy 2000 ·Journal of the American College of Cardiology ·Shaun G. Goodman, Aiala Barr, (unknown), Marc Cohen, Gregg Fromell, Luc Laperrière, (unknown), Anatoly Langer	42
10	Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy 2000 ·American Heart Journal ·(unknown), Sandra S. Stinnett, Beth Davison Weatherley, Enrique Gurfinkel, Gregg Fromell, Shaun G. Goodman, Keith A.A. Fox, Robert M. Califf	25
11	Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial 1998 ·The American Journal of Cardiology ·Marc Cohen, Christine Demers, Enrique Gurfinkel, Alexander G.G. Turpie, Gregg Fromell, Shaun G. Goodman, Anatoly Langer, Robert M. Califf, Keith A.A. Fox, Jerôme Premmereur, Frédérique Bigonzi	68
12	One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non-Q-wave myocardial infarction) 1998 ·Journal of the American College of Cardiology ·Mauricio G. Cohen, Frédérique Bigonzi, (unknown), (unknown), Gregg Fromell, Shaun Goodman	7
13	A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease breakdown → 1997 ·New England Journal of Medicine ·Marc J. Cohen, Christine Demers, Enrique Gurfinkel, Alexander G.G. Turpie, Gregg Fromell, Shaun Goodman, Anatoly Langer, Robert M. Califf, Keith A.A. Fox, Jerôme Premmereur, Frédérique Bigonzi, (unknown), Beth Davison Weatherley	1004
14	The Essence Trial: Efficacy and Safety of Subcutaneous Enoxaparin in Unstable Angina and Non-Q-Wave MI: A Double-Blind, Randomized, Parallel-Group, Multicenter Study Comparing Enoxaparin and Intravenous Unfractionated Heparin: Methods and Design 1997 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), Christine Demers, Enrique Gurfinkel, (unknown), Gregg Fromell, Jerôme Premmereur, (unknown)	14
15	Dose‐Ranging Study of a New, Once‐Daily Diltiazem Formulation for Patients with Stable Angina 1995 ·The Journal of Clinical Pharmacology ·Neal R. Cutler, (unknown), Gregg Fromell, Eric P. Brass, Stephen Archer, Steven G. Chrysant, (unknown)	5
16	Conversion from immediate‐release to extended‐relase diltiazem in angina pectoris 1994 ·Clinical Cardiology ·Peter E. Pool, (unknown), Alan B. Miller, Gregg Fromell, (unknown)	2
17	Fluvastatin with and without niacin for hypercholesterolemia 1994 ·The American Journal of Cardiology ·Terry A. Jacobson, (unknown), Gregg Fromell, Leonard Jokubaitis, Louis F. Amorosa	80
18	The Wenckebach phenomenon 1986 ·Journal of Emergency Medicine ·Gregg Fromell, (unknown), Robert A. Barish	4
19	Effect of Mount St. Helens ash on the response of rat trachea to smooth muscle agonists 1981 ·Environmental Research ·Jeffrey S. Fedan, Jane Ma, Gregg Fromell, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact